Advertisement

Somatomedins (Insulin-Like Growth Factors) and the Nervous System

  • Yutaka Oomura
  • Carlos R. Plata-Salamán

Abstract

Somatomedin is a general term which refers to plasma factors that have both growth-promoting (stimulate sulfate incorporation into chondroitin sulfate of cartilage and increase thymidine incorporation into DNA in various tissues) and insulin-like effects (in adipose tissue and diaphragm, not neutralized by anti-insulin serum)1,2. “Somato” relates to somatotropin (growth hormone, GH) and also to the soma which is the target and “medin” to indicate it mediates the action of GH.

Keywords

Growth Hormone Glia Maturation Factor Multiplication Stimulate Activity Somatomedin Activity Cerebral Gigantism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    W. H. Daughaday, K. Hall, M. S. Raben, W. D. Salmon, J. L. Van den Brande, and J. J. Van Wyk, Somatomedin: A proposed designation for the “sulfation factor”, Nature. 235: 107 (1972).PubMedCrossRefGoogle Scholar
  2. 2.
    R. H. Chochinov, and W. H. Daughaday, Current concepts of somatomedin and other biologically related growth factors, Diabetes. 25: 994 (1976).PubMedCrossRefGoogle Scholar
  3. 3.
    H. Sievertsson, L. Fryklund, K. Uthne, K. Hall, and B. Westermark, Isolation and chemistry of human somatomedins A and B, Adv. Metab. Disord. 8: 47 (1975).Google Scholar
  4. 4.
    K. Hall, Human somatomedin: Determination, occurrences, biological activity and purification, Acta Endocrinol. 163: 1 (1972).Google Scholar
  5. 5.
    J. J. Van Wyk, and L. E. Underwood, The somatomedins and their actions, Biochem. Actions Horm. 5: 101 (1978).Google Scholar
  6. 6.
    K. Uthne, Human somatomedins. Purification and some studies on their biological actions, Acta Endocrinol. (Suppl.) 175: 1 (1973).Google Scholar
  7. 7.
    J. J. Van Wyk, L. E. Underwood, R. L. Hintz, D. R. Clemmons, S. J. Voina, and R. P. Weaver, The somatomedins: A family of insulinlike hormones under growth hormone control, Recent Prog. Horm. Res. 30: 259 (1974).Google Scholar
  8. 8.
    A. C. Moses, S. P. Nissley, P. A. Short, M. M. Rechler, and J. M. Podskalny, Purification and characterization of multiplication stimulating activity, Eur. J. Biochem. 103: 387 (1980).PubMedCrossRefGoogle Scholar
  9. 9.
    N. A. Samaan, W. J. Dempster, R. Fraser, M. W. Please, and D. Stillman, Further immunological studies on the form of circulating insulin, J. Endocrinol. 24: 263 (1962).PubMedCrossRefGoogle Scholar
  10. 10.
    E. R. Froesch, H. Bürgi, W. A. Miller, R. E. Humbel, A. Jacob, and A. Lambert, Antibody-suppressible and nonsuppressible insulin-like activity in human serum and their physiological significance. An insulin assay with adipose tissue of increased precision and specificity, J. Clin. Invest. 42: 1816 (1963).PubMedCrossRefGoogle Scholar
  11. 11.
    E. Rinderknecht, and R. E. Humbel, Amino-terminal sequences of two polypeptides from human serum with non-suppressible insulin-like and cell-growth-promoting activities: Evidence for structural homology with insulin B chain, Proc. Natl. Acad. Sci., U.S.A. 73: 4379 (1976).PubMedCrossRefGoogle Scholar
  12. 12.
    E. Rinderknecht, and R.E. Humbel, Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: Isolation, chemical characterization and some biological properties of forms I and II, Proc. Natl. Acad. Sci., U.S.A. 73: 2365 (1976).PubMedCrossRefGoogle Scholar
  13. 13.
    B. I. Posner, H. J. Guyda, M. T. Corvol, R. Rappaport, C. Harley, and S. Goldstein, Partial purification, characterization and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma, J. Clin. Endocrinol. Metab. 47: 1240 (1978).PubMedCrossRefGoogle Scholar
  14. 14.
    G. Enberg, M. Carlquist, H. Jörnvall, and K. Hall, The characterization of somatomedin A, isolated by microcomputer - controlled chromatography, reveals an apparent identity to insulin-like growth factor I, Eur. J. Biochem. 143: 117 (1984).Google Scholar
  15. 15.
    D. G. Klapper, M. E. Svoboda, and J. J. Van Wyk, Sequence analysis of somatomedin C: Confirmation of identity with insulin-like growth factor I, Endocrinology. 112: 2215 (1983).PubMedCrossRefGoogle Scholar
  16. 16.
    H. Marquardt, G. J. Todaro, L. E. Henderson, and S. Oroszlan, Purification and primary structure of a polypeptide with multiplication-simulating activity (MSA) from rat liver cell cultures: Homology with human insulin-like growth factor II (IGF-II), J. Biol. Chem. 256: 6859 (1981).PubMedGoogle Scholar
  17. 17.
    A. C. Moses, S. P. Nissley, P. A. Short, M. M. Rechler, R. M. White, A. B. Knight, and O.Z. Higa, Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum, Proc. Natl. Acad. Sci., U.S.A. 77: 3649 (1980).PubMedCrossRefGoogle Scholar
  18. 18.
    C. H. Heldin, A. Wasteson, L. Fryklund, and B. Westermark, Somatomedin B: Mitogenic activity derived from contaminant epidermal growth factor, Science. 213: 1122 (1981).PubMedCrossRefGoogle Scholar
  19. 19.
    G. Haselbacher and R. Humbel, Evidence for two species of insulin-like growth factor II (IGF II and “big” IGF II) in human spinal fluid, Endocrinology 110: 1822 (1982).PubMedCrossRefGoogle Scholar
  20. 20.
    M. Jansen, F. M. A. Van Schaik, H. Van Tol, J. L. Van den Brande, and J. S. Sussenbach, Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant, FEBS Lett. 179: 243 (1985).PubMedCrossRefGoogle Scholar
  21. 21.
    J. L. Van den Brande, M. Jansen, C. M. Hoogerbrugge, P. de Pagter-Holthuizen, S. C. van Buul-Offers, F.M.A Van Schaik, and J. S. Sussenbach, Molecular aspects of the human somatomedins, Horm. Res. 24: 131 (1986).Google Scholar
  22. 22.
    E. Rinderknecht, and R.E. Humbel, The amino acid sequence of insulin-like growth factor I and its structural homology with proinsulin, J. Biol. Chem. 253: 2769 (1978).PubMedGoogle Scholar
  23. 23.
    J. Zapf, C. H. Schmid, and E. R. Froesch, Biological and immunological properties of insulin-like growth factors (IGF) I and II, Clin. Endocrinol. Metab. 13: 3 (1984).Google Scholar
  24. 24.
    J. J. Van Wyk, The somatomedins: Biological actions and physiologic control mechanisms, in: “Human Proteins and Peptides,” C. H. Li, ed., Academic Press, New York (1984).Google Scholar
  25. 25.
    E. Rinderknecht and R. E. Humbel, Primary structure of human insulin-like growth factor-II, FEBS Lett. 89: 283 (1978).PubMedCrossRefGoogle Scholar
  26. 26.
    L. E., Underwood, A. J. D’Ercole, D. R. Clemmons, and J. J. Van Wyk, Paracrine functions of somatomedins, Clin. Endocrinol. Metab. 15: 59 (1986).Google Scholar
  27. 27.
    J. F. Perdue, Chemistry, structure, and function of insulin-like growth factors and their receptors: a review, Can. J. Biochem. Cell Biol. 62: 1237 (1984).PubMedCrossRefGoogle Scholar
  28. 28.
    E. R. Froesch, and J. Zapf, Insulin-like growth factors and insulin: Comparative aspects, Diabetologia 28: 485 (1985).PubMedCrossRefGoogle Scholar
  29. 29.
    R. C. Baxter, The somatomedins: Insulin-like growth factors, Adv. Clin. Chem. 25: 49 (1986).CrossRefGoogle Scholar
  30. 30.
    D. R. Clemmons, and L. E. Underwood, Somatomedin-C/Insulin-like growth factor I in acromegaly, Clin. Endocrinol. Metab. 15: 629 (1986).Google Scholar
  31. 30a.
    a.G. I. Bell, J. P. Merryweather, R. Sanchez-Pescador, M. M. Stempien, L. Preistly, J. Scott, and L. B. Rall, Sequence of a cDNA clone encoding human preproinsulin-like growth factor II, Nature 310: 775 (1984).PubMedCrossRefGoogle Scholar
  32. 31.
    T. L. Blundell, S. Bedarkar, E. Rinderknecht, and R. E. Humbel, Insulin-like growth factor: A model for tertiary structure accounting for immunoreactivity and receptor binding, Proc. Natl. Acad. Sci., U.S.A. 75: 180 (1978).PubMedCrossRefGoogle Scholar
  33. 32.
    T. L. Blundell, and R. E. Humbel, Hormone families: Pancreatic hormones and homologous growth factors, Nature 287: 781 (1980).PubMedCrossRefGoogle Scholar
  34. 33.
    J. Zapf, and E. R. Froesch, Insulin-like growth factors/somatomedins: Structure, secretion, biological actions and physiological role, Horm. Res. 24: 121 (1986).Google Scholar
  35. 34.
    P. McConaghey, and C. B. Sledge, Production of “sulphation factor” by the perfused rat liver, Nature 225: 1249 (1970).PubMedCrossRefGoogle Scholar
  36. 35.
    M. J. 0. Francis, and D. J. Hill, Prolactin-stimulated production of somatomedin by rat liver, Nature 255: 167 (1975).CrossRefGoogle Scholar
  37. 36.
    M. Kogawa, K. Takano, K. Asakawa, N. Hizuka, T. Tsushima, and K. Shizume, Insulin stimulation of somatomedin A production in monolayer cultures of rat hepatocytes, Acta Endocrinol. 103: 385 (1983).PubMedGoogle Scholar
  38. 37.
    J. C. Schwander, C. Hauri, J. Zapf, and E. R. Froesch, Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: Dependence on growth hormone status, Endocrinology. 113: 297 (1983).PubMedCrossRefGoogle Scholar
  39. 38.
    C. D. Scott, J. L. Martin, and R. C. Baxter, Production of insulin-like growth factor-I and its binding protein by adult rat hepatocytes in primary culture, Endocrinology 116: 1094 (1985).PubMedCrossRefGoogle Scholar
  40. 39.
    P. R. Atkinson, E. R. Weidman, B. Bhaumick, and R. M. Bala, Release of somatomedin-like activity by cultured WI-38 human fibroblasts, Endocrinology. 106: 2006 (1980).Google Scholar
  41. 40.
    D. R. Clemmons, Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts, J. Clin. Endocrinol. Metab. 58: 850 (1984).PubMedCrossRefGoogle Scholar
  42. 41.
    L. S. Phillips, A. C. Herington, I. E. Karl, and W. H. Daughaday, Comparison of somatomedin activity in perfusates of normal and hypophysectomized rat livers with and without added growth hormone, Endocrinology. 98: 606 (1976).PubMedCrossRefGoogle Scholar
  43. 42.
    J. A. Romanus, A. Rabinovitch, and M. M. Rechler, Neonatal rat islet cell cultures synthesize insulin-like growth factor I, Diabetes 34: 696 (1985).PubMedCrossRefGoogle Scholar
  44. 43.
    K. Hall and M. Bozovic, Stimulation of 35S incorporation into embryonic chick cartilage by extracts from rat muscle, Horm. Metab. Res. 1: 235 (1969).CrossRefGoogle Scholar
  45. 44.
    V. R. Sara, K. Uvnas-Moberg, B. Uvnas, K. Hall, L. Wetterberg, B. Posloncec, and M. Goiny, The distribution of somatomedins in the nervous system of the cat and their release following neural stimulation, Acta Physiol. Scand. 115: 467 (1982).CrossRefGoogle Scholar
  46. 45.
    K. Kawai, K. Takano, N. Hizuka, and K. Shizume, Properties and concentrations of somatomedin A in various rat tissues, Endocrinol. Jpn. 26: 559 (1979).Google Scholar
  47. 46.
    A. J. D’Ercole, G. T. Applewhite, and L. E. Underwood, Evidence that somatomedin is synthesized by multiple tissues in the fetus, Dev. Biol. 75: 315 (1980).Google Scholar
  48. 47.
    R. C. Baxter, Z. Zaltsman, and J. R. Turtle, Immunoreactive somatomedin-C/insulin-like growth factor-I and its binding protein in human milk, J. Clin. Endocrinol. Metab. 58: 955 (1984).PubMedCrossRefGoogle Scholar
  49. 48.
    R. C. Baxter, J. L. Martin, and D. J. Handelsman, Identification of human semen insulin-like growth factor-I/somatomedin-C immunoreactivity and binding protein, Acta Endocrinol. 106: 420 (1984).PubMedGoogle Scholar
  50. 49.
    A. J. D’Ercole, A. D. Stiles, and L. E. Underwood, Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action, Proc. Natl. Acad. Sci., U.S.A. 81: 935 (1984).PubMedCrossRefGoogle Scholar
  51. 50.
    D. R. Clemmons, Variables controlling the secretion of a somatomedin-like peptide by cultured porcine smooth muscle cells, Circ. Res. 56: 418 (1985).Google Scholar
  52. 51.
    D. R. Clemmons, and D. S. Shaw, Variables controlling somatomedin production by cultured human fibroblasts. J. Cell. Physiol. 115: 137 (1983).PubMedCrossRefGoogle Scholar
  53. 52.
    D. R. Clemmons and J. J. Van Wyk, Evidence for a functional role of endogenously produced somatomedin-like peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells, J. Clin. Invest. 75: 1914 (1985).PubMedCrossRefGoogle Scholar
  54. 53.
    M. Binoux, P. Hossenlopp, C. Lassarre, and N. Hardouín, Production of insulin-like growth factors and their carrier by rat pituitary gland and brain explants in culture, FEBS Lett. 124: 178 (1981).PubMedCrossRefGoogle Scholar
  55. 54.
    G. K. Haselbacher, M. E. Schwab, A. Pasi, and R. E. Humbel, Insulin-like growth factor II (IGF II) in human brain: Regional distribution of IGF II and of higher molecular mass forms, Proc. Natl. Acad. Sci., U.S.A. 82: 2153 (1985).PubMedCrossRefGoogle Scholar
  56. 55.
    T. J. Lauterio, L. Marson, W. H. Daughaday, and C. A. Balle, Intracerebroventricular injections of insulin-like growth factor II, but not insulin-like growth factor I, decrease food intake and body weight in rats, Soc. Neurosci. Abst. 12: 795 (1986).Google Scholar
  57. 56.
    V.R. Sara, K. Hall, C. H. Rodeck, and L. Wetterberg, Human embryonic somatomedin, Proc. Natl. Acad. Sci., U.S.A. 7$: 3175 (1981).Google Scholar
  58. 57.
    V. R. Sara, K. Hall, M. Misaki, L. Fryklund, N. Christensen, and L. Wetterberg, Ontogenesis of somatomedin and insulin receptors in the human fetus, J. Clin. Invest. 71: 1084 (1983).PubMedCrossRefGoogle Scholar
  59. 58.
    G. Enberg, A. Tham, and V. R. Sara, The influence of purified somatomedins and insulin on foetal rat brain DNA synthesis in vitro, Acta Physiol. Scand. 125: 305 (1985).CrossRefGoogle Scholar
  60. 59.
    V. R. Sara, C. Carlsson-Skwirut, C. Andersson, E. Hall, B. Sjögren, A. Holmgren, and H. Jörnvall, Characterization of somatomedins from human fetal brain: Identification of a variant form of insulin-like growth factor I, Proc. Natl. Acad. Sci., U.S.A. 83: 4904 (1986).PubMedCrossRefGoogle Scholar
  61. 60.
    C. Carlsson-Skwirut, H. Jörnvall, A. Holmgren, C. Andersson, T. Bergman, G. Lundquist, B. Sjögren, and V.R. Sara, Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain, FEBS Lett. 201: 46 (1986).PubMedCrossRefGoogle Scholar
  62. 61.
    P. K. Lund, B. M. Moats-Staats, M. A. Hynes, J. G. Simmons, M. Jansen, A. J. D’Ercole, and J. J. Van Wyk, Somatomedin-C/Insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues, J. Biol. Chem. 261: 14539 (1986).PubMedGoogle Scholar
  63. 62.
    P. P. Zumstein, C. Lüthi, and R. E. Humbel, Amino acid sequence of a variant pro-form of insulin-like growth factor II, Proc. Natl. Acad. Sci., U.S.A. 82: 3169 (1985)PubMedCrossRefGoogle Scholar
  64. 63.
    M. C. Soares, D. N. Ishii, and A. Efstratiadis, Developmental and tissue-specific expression of a family of transcripts related to rat insulin-like growth factor II mRNA, Nucleic Acids Res. 13: 1119 (1985).PubMedCrossRefGoogle Scholar
  65. 64.
    J. Scott, J. Cowell, M. E. Robertson, L. M. Priestley, R. Wadey, B. Hopkins, J. Pritchard, G. I. Bell, L. B. Rall, C. F. Graham, and T. J. Knott, Insulin-like growth factor-II gene expression in Wilms’ tumour and embryonic tissues, Nature. 317: 260 (1985).PubMedCrossRefGoogle Scholar
  66. 65.
    A. L. Brown, D. E. Graham, S. P. Nissley, D. J. Hill, A. J. Strain, and M. M. Rechler, Developmental regulation of insulin-like growth factor II mRNA in different rat tissues, J. Biol. Chem. 261: 13144 (1986).PubMedGoogle Scholar
  67. 66.
    G. R. Beaton, J. Sagel and L. A. Distiller, Somatomedin activity in cerebrospinal fluid, J. Clin. Endocrinol. Metab. 40: 736 (1975).PubMedCrossRefGoogle Scholar
  68. 67.
    M. Backstrom, K. Hall, and V. Sara, Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders, Acta Endocrinol. 107: 171 (1984).PubMedGoogle Scholar
  69. 68.
    K. Hall and V. R. Sara, Growth and somatomedins, Vit. Horm. 40: 175 (1983).Google Scholar
  70. 69.
    K. Hall and V. R. Sara, Somatomedin levels in childhood adolescence and adult life, Clin. Endocrinol. J. Metabolism 13: 91 (1984).Google Scholar
  71. 70.
    A. C. Moses, S. P. Nissley, K. L. Cohen, and M. M. Rechler, Specific binding of somatomedin-like polypeptide in rat serum depends on growth hormone, Nature 263: 137 (1976).PubMedCrossRefGoogle Scholar
  72. 71.
    R. L. Hintz, F. Liu, R. G. Rosenfeld, and S. F. Kemp, Plasma somatomedin-binding proteins in hypopituitarism: Changes during growth hormone therapy, J. Clin. Endocrinol. Metab. 53: 100 (1981).PubMedCrossRefGoogle Scholar
  73. 72.
    R. M. White, S. P. Nissley, A. C. Moses, M. M. Rechler, and R. E. Johnsonbaugh, The growth hormone dependence of a somatomedin-binding protein in human serum, J. Clin. Endocrinol. Metab. 53: 49 (1981).PubMedCrossRefGoogle Scholar
  74. 73.
    D. H. Morris, and D. S. Schalch, Structure of somatomedin-binding protein: Alkaline GH induced dissociation of an acid-stable, 60,000 molecular weight complex into smaller components, Endocrinology. 111: 801 (1982).PubMedCrossRefGoogle Scholar
  75. 74.
    D. A. Cohen and S. L. Blethen, Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels, J. Clin. Endocrinol. Metab. 56: 461 (1983).PubMedCrossRefGoogle Scholar
  76. 75.
    S. L. S. Drop, D. J. Kortleve, and H. J. Guyda, Isolation of a somatomedin-binding protein from preterm amniotic fluid: Development of a radioimmunoassay, J. Clin. Endocrinol. Metab. 59: 899 (1984).PubMedCrossRefGoogle Scholar
  77. 76.
    J. R.: Wilkins and J. D’Ercole, Affinity labeled plasma somatomedin-C/insulin-like growth factor I binding proteins: Evidence of growth hormone dependence and subunit structure, J. Clin. Invest. 75: 1350 (1985).PubMedCrossRefGoogle Scholar
  78. 77.
    W. H. Daughaday, A. P. Ward, A. C. Goldberg, B. Trivedi, and M. Kapadia, Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration, J. Clin. Endocrinol. Metab. 55: 916 (1982).PubMedCrossRefGoogle Scholar
  79. 78.
    M. Binoux, P. Hossenlopp, S. Hardouin, D. Seurin, C. Lassarre, and M. Gourmelen, Somatomedin (Insulin-like growth factors) - binding proteins, Horm. Res. 24: 141 (1986).Google Scholar
  80. 79.
    M. Binoux, S. Haradouin, C. Lassarre, and P. Hossenlopp, Evidence for production by the liver of two IGF binding proteins with similar molecular weights but different affinities for IGF I and IGF II. Their relations with serum and cerebrospinal fluid IGF binding proteins, J. Clin. Endocrinol. Metab. 55: 600 (1982).PubMedCrossRefGoogle Scholar
  81. 80.
    M. Binoux, C. Lassarre, and M. Gourmelen, Specific assay for insulin-like growth factor (IGF) II using the IGF binding proteins extracted from human cerebrospinal fluid, J. Clin. Endocrinol. Metab. 63: 1151 (1986).PubMedCrossRefGoogle Scholar
  82. 81.
    V. K. M. Han, D. F. Bell, J. M. Lauder, and A. J. D’Ercole, Characterization of somatomedin/insulin-like growth factor (Sm/IGF) binding proteins (BPs) in conditioned medium from rat astroglia by affinity labeling, Soc. Neurosci. Abst. 12: 397 (1986).Google Scholar
  83. 82.
    K. L. Cohen and S. P. Nissley, The serum half-life of somatomedin activity: Evidence for growth hormone dependence, Acta Endocrinol. 83: 243 (1976).PubMedGoogle Scholar
  84. 83.
    G. L. Smith, Somatomedin carrier protein, Mol. Cell. Endocrinol. 34: 83 (1984).CrossRefGoogle Scholar
  85. 84.
    R. L. Hintz, Plasma forms of somatomedin and the binding protein phenomenon, Clin. Endocrinol. Metab. 13: 31 (1984).Google Scholar
  86. 85.
    D. R. Clemmons, L. E. Underwood, P. G. Chatelain and J. J. Van Wyk, Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin, J. Clin. Endocrinol. Metab. 56: 384 (1983).PubMedCrossRefGoogle Scholar
  87. 86.
    P. G. Chatelain, J. J. Van Wyk, K. C. Copeland, S. L. Blethen, and L. E. Underwood, Effect of in vitro action of serum proteases or exposure to acid on measurable immunoreactive somatomedin-C in serum, J. Clin. Endocrinol. Metab. 56: 376 (1983).PubMedCrossRefGoogle Scholar
  88. 87.
    E. M. Spencer, Synthesis by cultured hepatocytes of somatomedin and its binding protein, FEBS Lett. 99: 157 (1979).PubMedCrossRefGoogle Scholar
  89. 88.
    A. C. Moses, S. P. Nissley, J. Passamani and R. M. White, Further characterization of GH-dependent somatomedin-binding protein in rat serum and demonstration of somatomedin-binding protein produced by rat liver cells in culture, Endocrinology 104: 536 (1979).PubMedCrossRefGoogle Scholar
  90. 89.
    K. C. Copeland, L. E. Underwood, and J. J. Van Wyk, Induction of immunoreactive somatomedin C in human serum by growth hormone: Dose-response relationships and effect on chromatographic profiles, J. Clin. Endocrinol. Metab. 50: 690 (1980).PubMedCrossRefGoogle Scholar
  91. 90.
    M. Binoux, D. Seurin, C. Lassarre, and M. Gourmelen, Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels, J. Clin. Endocrinol. Metab. 59: 453 (1984).PubMedCrossRefGoogle Scholar
  92. 91.
    V. R. Sara, K. Hall, H. Von Holtz, R. Humbel, B. Sjögren, and L. Wetterberg, Evidence for the presence of specific receptors for insulin-like growth factors I (IGF-I) and II (IGF-II) and insulin throughout the adult human brain, Neurosci. Lett. 34: 39 (1982).Google Scholar
  93. 92.
    C. G. Goodyer, L. De Stephano, W. H. Lai, H. J. Guyda, and B. I. Posner, Characterization of insulin-like growth factor receptors in rat anterior pituitary, hypothalamus and brain, Endocrinology 114: 1187 (1984).PubMedCrossRefGoogle Scholar
  94. a.J. D. Grizzard, A. J. D’Ercole, J. R. Wilkins, B. M. Moats-Staats, and R. W. Williams, Affinity-labeled somatomedin-C receptors and binding proteins from the human fetus, J. Clin. Endocrinol. Metab. 58: 535 (1984).CrossRefGoogle Scholar
  95. 93.
    B. Bhaumick, R. M. Bala, and M. D. Hollenberg, Somatomedin receptor of human placenta: Solubilization, photolabeling, partial purification, and comparison with insulin receptor. Proc. Natl. Acad. Sci., U.S.A. 78: 4278 (1981).CrossRefGoogle Scholar
  96. 94.
    S. D. Chernausek, S. Jacobs, and J. J. Van Wyk, Structural similarities between human receptors for somatomedin C and insulin: Analysis by affinity labeling, Biochemistry 20: 7345 (1981).PubMedCrossRefGoogle Scholar
  97. 95.
    M. Kasuga, E. Van Obberghen, S. P. Nissley, and M. M. Rechler, Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking, J. Biol. Chem. 256: 5305 (1981).PubMedGoogle Scholar
  98. 96.
    B. Bhaumick, G. D. Armstrong, M. D. Hollenberg, and R. M. Bala, Characterization of the human placental receptor for basic somatomedin, Can. J. Biochem. 60: 923 (1982).Google Scholar
  99. 97.
    J. Massague, and M. P. Czech, The subunit structure of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor, J. Biol. Chem. 257: 5038 (1982).PubMedGoogle Scholar
  100. 98.
    D. 0. Morgan, K. Jarnagin, and R. A. Roth, Purification and characterization of the receptor for insulin-like growth factor I, Biochemistry 25: 5560 (1986).CrossRefGoogle Scholar
  101. 99.
    K-T, Yu, M. A. Peters, and M.P. Czech, Similar control mechanisms regulate the insulin and type I insulin-like growth factor receptor kinases, J. Biol. Chem. 261: 11341 (1986).Google Scholar
  102. 100.
    G. P. August, S. P. Nissley, M. Kasuga, L. Lee, L. Greenstein, and M. M. Rechler, Purification of an insulin-like growth factor II receptor from rat chondrosarcoma cell, J. Biol. Chem. 258: 9033 (1983).PubMedGoogle Scholar
  103. 101.
    C. L. Oppenheimer, and M. P. Czech, Purification of the type II insulin-like growth factor receptor from rat placenta, J. Biol. Chem. 258: 8539 (1983).PubMedGoogle Scholar
  104. 102.
    C. Thibault, J. K. Chan, J. F. Perdue, and W. H. Daughaday, Insulin-like growth factor receptors: Molecular radius and molecular weight determination using quantitative polyacrylamide gel electrophoresis, J. Biol. Chem. 259: 3361 (1984).PubMedGoogle Scholar
  105. 103.
    M. P. Czech, C. L. Oppenheimer, and J. Massague, Interrelationships among receptor structures for insulin and peptide growth factors, Fed. Proc. 42: 2598 (1983).Google Scholar
  106. 104.
    M. M. Rechler and S. P. Nissley, The Nature and regulation of the receptors for insulin-like growth factors, Ann. Rev. Physiol. 47: 425 (1985).CrossRefGoogle Scholar
  107. 105.
    H. A. Jonas, R. C. Baxter, and L. C. Harrison, Structural differences between insulin and somatomedin-C/insulin-like growth factor-I receptors revealed by autoantibodies to the insulin receptor, Biochem. Biophys. Res. Commun. 109: 463 (1982).CrossRefGoogle Scholar
  108. 106.
    M. Kasuga, N. Sasaki, C. R. Kahn, S. P. Nissley, and M. M. Rechler, Antireceptor antibodies as probes of insulinlike growth factor receptor structure, J. Clin. Invest. 72: 1459 (1983).PubMedCrossRefGoogle Scholar
  109. 107.
    F. C. Kull, S. Jacobs, Y. F. Su, M. E. Svoboda, J. J. Van Wyk, and P. Cuatrecasas, Monoclonal antibodies to receptors for insulin and somatomedin-C, J. Biol. Chem. 258: 6561 (1983).PubMedGoogle Scholar
  110. 108.
    C. A. Stuart, R. Pietrzyk, A. K. Q. Siu, and R. W. Furlanetto, Size discrepancy between somatomedin-C and insulin receptors, J. Clin. Endocrinol. Metab. 58: 1 (1984).PubMedCrossRefGoogle Scholar
  111. 109.
    M. M. Rechler, and S. P. Nissley, Insulin-like growth factor (IGF)/somatomedin receptor subtypes: Structure, function, and relationships to insulin receptors and IGF carrier proteins, Horm. Res. 24: 152 (1986).Google Scholar
  112. 110.
    H. A. Jones, J. D. Neuman, and L. C. Harrison, An atypical insulin receptor with high affinity for insulin-like growth factors copurified with placental insulin receptors, Proc. Natl. Acad. Sci., U.S.A. 83: 4124 (1986).CrossRefGoogle Scholar
  113. 110a.
    a.R. L. Hintz, A. V. Thorsson, G. Enberg, and K. Hall, IGF-II binding on human lymphoid cells: Demonstration of a common high affinity receptor for insulin like peptides, Biochem. Biophys. Res. Commun. 118: 774 (1984).CrossRefGoogle Scholar
  114. 111.
    B. I. Posner, R. M. Gonzalez, and H. J. Guyda, Intracellular (golgi) receptors for insulinlike peptides in rat liver, Can. J. Biochem. 58: 1075 (1980).Google Scholar
  115. 112.
    G. L. King, C. R. Kahn, M. M. Rechler, and S. P. Nissley, Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor, J. Clin. Invest. 66: 130 (1980).PubMedCrossRefGoogle Scholar
  116. 113.
    M. M. Rechler, S. P. Nissley, G. L. King, A. C. Moses, E. E. Van Obberghen-Schilling, J. A. Romanus, A. B. Knight, P. A. Short, and R. M. White, Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: Relation to human somatomedins and insulin, J. Supramol. Struc. Cell Biochem. 15: 253 (1981).CrossRefGoogle Scholar
  117. 114.
    S. J. Pilistine, A. C. Moses, and H. N. Munro, Insulin-like growth factor receptors in rat placental membranes, Endocrinology. 115: 1060 (1984).PubMedCrossRefGoogle Scholar
  118. 115.
    R. G. Rosenfeld, and L. A. Dollar, Characterization of the somatomedin-C/insulin-like growth factor 1 (SM-C/IGF-1) receptor on cultured human fibroblast monolayers: Regulation of receptor concentrations by SM-C/IGF-1 and insulin, J. Clin. Endocrinol. Metab. 55: 434 (1982).PubMedCrossRefGoogle Scholar
  119. 116.
    R. G. Rosenfeld, R. L. Hintz, and L. A. Dollar, Insulin-induced loss of insulin-like growth factor-I receptors on IM-9 lymphocytes, Diabetes. 31: 375 (1982).PubMedCrossRefGoogle Scholar
  120. 117.
    C. L. Oppenheimer, J. E. pessin, J. Massague, W. Gítomer, and M. P. Czech, Insulin action rapidly modulates the apparent affinity of the insulin-like growth factor II receptor, J. Biol. Chem. 258: 4824 (1983).PubMedGoogle Scholar
  121. 118.
    N. Potau, J. Mossner, J. A. Williams, and I. D. Goldfine, Cholecystokinin and insulin regulate insulin-like growth factor II binding to pancreatic receptors; evidence of a role for intracellular calcium. Biochem. Biophys. Res. Commun. 119: 359 (1984).PubMedCrossRefGoogle Scholar
  122. 119.
    L. J. Wardzala, I. A. Simpson, M. M. Rechler, and S. W. Cushman, Potential mechanism of the stimulatory action of insulin on insulin-like growth factor II binding to the isolated rat adipose cell: Apparent redistribution of receptors recycling between a large intracellular pool and the plasma membrane, J. Biol. Chem. 259: 8378 (1984).PubMedGoogle Scholar
  123. 120.
    Y. Oka, C. Mottola, C. L. Oppenheimer, and M. P. Czech, Insulin activates the appearance of insulin-like growth factor II receptors on the adipocyte cell surface, Proc. Natl. Acad. Sci., U.S.A. 81: 4028 (1984).PubMedCrossRefGoogle Scholar
  124. 121.
    Y. Oka, L. M. Rozek, and M. P. Czech, Direct demonstration of rapid insulin-like growth II receptor internalization and recycling in rat adipocytes, J. Biol. Chem. 260: 9435 (1985).PubMedGoogle Scholar
  125. 122.
    Y. Oka and M. P. Czech, The type II insulin-like growth factor receptor is internalized and recycles in the absence of ligand, J. Biol. Chem. 261: 9090 (1986).PubMedGoogle Scholar
  126. 123.
    R. C. Baxter and P. F. Williams, Reciprocal modulation of insulin and insulin-like growth factor-I receptor affinity by calcium. Biochem. Biophys. Res. Commun. 116: 62 (1983).PubMedCrossRefGoogle Scholar
  127. 124.
    S. Jacobs, F. C. Kull, H. S. Earp, M. E. Svoboda, J. J. Van Wyk, and P. Cuatrecasas, Somatomedin-C stimulates the phosphorylation of the ß-subunit of its own receptor, J. Biol. Chem. 258: 9581 (1983).PubMedGoogle Scholar
  128. 125.
    J. B. Rubin, M. A. Shia, and P. F. Pilch, Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I, Nature. 305: 438 (1983).PubMedCrossRefGoogle Scholar
  129. 126.
    Y. Zick, N. Sasaki, R. W. Rees-Jones, G. Grunberger, S. P. Nissley and M. M. Rechler, Insulin-like growth factor-I (IGF-I) stimulates tyrosine kinase activity in purified receptors from a rat liver cell line, Biochem. Biophys. Res. Commun. 119: 6 (1984).CrossRefGoogle Scholar
  130. 127.
    N. Sasaki, R. W. Rees-Jones, Y. Zick, S. P. Nissley, and M. M. Rechler, Characterization of insulin-like growth factor I-stimulated tyrosine kinase activity associated with the ß-subunit of type I insulin-like growth factors receptors of rat liver cells, J. Biol. Chem. 260: 9793 (1985).PubMedGoogle Scholar
  131. 128.
    S. Corvera, R. E. Whitehead, C. Mottola, and M. P. Czech, The insulin-like growth factor II receptor is phosphorylated by a tyrosine kinase in adipocyte plasma membranes, J. Biol. Chem. 261: 7675 (1986).PubMedGoogle Scholar
  132. 129.
    R. G. Rosenfeld, G. Ceda, D. M. Wilson, L. A. Dollar, and A. R. Hoffman, Characterization of high affinity receptors for insulin-like growth factors I and II on rat anterior pituitary cells, Endocrinology. 114: 1571 (1984).PubMedCrossRefGoogle Scholar
  133. 130.
    G. P. Ceda, A. R. Hoffman, G. D. Silverberg, D. M. Wilson, and R. G. Rosenfeld, Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin, J. Clin. Endocrinol. Metab. 60: 1204 (1985).PubMedCrossRefGoogle Scholar
  134. a.C. F. H. Van Schravendijk, E. L. Hooghe-Peters, J. L. Van den Brande, and D. G. Pipeleers, Receptors for insulin-like growth factors and insulin on murine fetal cortical brain cells, Biochem. Biophys. Res. Commun. 135: 228 (1986).Google Scholar
  135. 131.
    M. E. K. Mattsson, G. Enberg, A.-I. Ruusala, K. Hall, and S. Pahlman, Mitogenic response of human SH-SY5Y neuroblastoma cells to insulin-like growth factor I and II is dependent on the stage of differentiation, J. Cell Biol. 102: 1949 (1986).PubMedCrossRefGoogle Scholar
  136. 132.
    R. G. Rosenfeld, G. Ceda, C. W. Cutler, L. A. Dollar, and A. R. Hoffman, Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells, Endocrinology. 117: 2008 (1985).Google Scholar
  137. 123a.
    Gammeltoft, G. K. Haselbacher, R. E. Humbel, M. Fehlmann, and E. Van Obberghen, Two types of receptor for insulin-like growth factors in mammalian brain, EMBO J. 4: 3407 (1985).Google Scholar
  138. 133.
    W. L. Lowe, Jr., and D. LeRoith, Tyrosine kinase activity of brain insulin and IGF-I receptors, Biochem. Biophys. Res. Commun. 134: 532 (1986).CrossRefGoogle Scholar
  139. 134.
    M. A. Leswiak, J. 25 Hill, C. B.iÏ rt, and J. Roth, Autoradiographic localization of I-IGFI and I-IGFII receptors in rat brain: Comparison with insulin receptors, Diabetes. 35, Suppl. 1: 58A (1986).Google Scholar
  140. 135.
    L. G. Mendelsohn, G. A. Kerchner, J. A. Clemens, and M. C. Smith, Autoradiographic visualization of insulin-like growth factor-II receptors in rat brain, Fed. Proc. 45: 325 (1986).Google Scholar
  141. 136.
    N. J. Bohannon, E. S. Corp, B. J. Wilcox, D. Porte, Jr., D. P. Figlewicz, and D. G. Baskin, Identification of specific binding sites for insulin-like growth factor-1 (IGF-1) in the rat brain by in vitro quantitative autoradiography, Appetite 7: 243 (1986).Google Scholar
  142. 137.
    N. J. Bohannon, D. P. Figlewicz, E. S. Corp, B. J. Wilcox, D. Porte, Jr., and D. G. Baskin, Identification of binding sites for an insulin-like growth factor (IGF-I) in the median eminence of the rat brain by quantitative autoradiography, Endocrinology 119: 943 (1986).PubMedCrossRefGoogle Scholar
  143. 137a.
    a.F. A. McMorris, T. M. Smith, S. DeSalvo, and R. W. Furlanetto, Insulin-like growth factor I/somatomedin C: A potent inducer of oligodendrocyte development, Proc. Natl. Acad. Sci. USA 83: 822 (1986).PubMedCrossRefGoogle Scholar
  144. 138.
    R. Lim. J. F. Miller, D. J. Hicklin, A. C. Holm, and B. H. Ginsberg, Mitogenic activity of glia maturation factor, Exp. Cell Res. 159: 335 (1985).PubMedCrossRefGoogle Scholar
  145. 139.
    D. P. Figlewicz, D. G. Baskin, S. C. Woods, and D. Porte, Jr., Insulin and insulin-like growth factor-I (IGF-I) binding is decreased in the olfactory bulb (OB) but not the cerebral cortex of the obese Zucker fa/fa rat, Int. J. Obes. 9: A31 (1985).Google Scholar
  146. 140.
    K. A. Heidenreich, P. R. Gilmore, D. P. Figlewicz, and G. R. Freidenberg, The glycosylation of IGF-I receptors differs in human brain and placenta, Diabetes 35, Supp1. 1: 60A (1986).Google Scholar
  147. 141.
    M. Van Houten and B. I. Posner, Circumventricular organs: Receptors and mediators of direct peptide hormone action on brain, Adv. Metab. Disord. 10: 269 (1983).Google Scholar
  148. 142.
    H. J. L. Frank, W. M. Pardridge, W. L. Morris, R. G. Rosenfeld, and T. B. Choi, Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels, Diabetes. 35: 654 (1986).PubMedCrossRefGoogle Scholar
  149. 143.
    R. S. Bar, and M. Boes, Distinct receptors for IGF-1, IGF-2, and insulin are present on bovine capillary endothelial cells and large vessel endothelial cells, Biochem. Biophys. Res. Commun. 124: 203 (1984).CrossRefGoogle Scholar
  150. 144.
    I. Jialal, M. Crettaz, H. L. Hachiya, C. R. Kahn, A. C. Moses, S. M. Buzney, and G. L. King, Characterization of the receptors for insulin and the insulin-like growth factors on micro-and macrovascular tissues, Endocrinology. 117: 1222 (1985).PubMedCrossRefGoogle Scholar
  151. 145.
    G. L. King, D. A. Goodman, S. Buzney, A. Moses, and C. R. Kahn, Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta, J. Clin. Invest. 75: 1028 (1985).PubMedCrossRefGoogle Scholar
  152. 146.
    R. S. Bar, M. Boes, and M. Yorek, Processing of insulin-like growth factors I and II by capillary and large vessel endothelial cells, Endocrinology. 118: 1072 (1986).PubMedCrossRefGoogle Scholar
  153. 147.
    N. K. Banskota, J.-L. Carpentier, and G. L. King, Processing and release of insulin and insulin-like growth factor I by macro-and microvascular endothelial cells, Endocrinology 119: 1904 (1986).PubMedCrossRefGoogle Scholar
  154. 148.
    W.M. Pardridge, J. Eisenberg, and J. Yang, Human blood-brain barrier insulin receptor, J. Neurochem. 44: 1771 (1985).PubMedCrossRefGoogle Scholar
  155. 149.
    K. D. Dernovsek, and R. S. Bar, Processing of cell bound insulin by capillary and macrovascular endothelial cells in culture, Am. J. Physiol. 248: E244 (1985).PubMedGoogle Scholar
  156. 150.
    G. L. King and S. M. Johnson, Receptor mediated transport of insulin across endothelial cells, Science. 227: 1583 (1985).PubMedCrossRefGoogle Scholar
  157. 151.
    D. R. Clemmons, L. E. Underwood, and J. J. Van Wyk, Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts, J. Clin. Invest. 67: 10 (1981).PubMedCrossRefGoogle Scholar
  158. 152.
    M. Binoux, C. Lassarre, and N. Hardouin, Somatomedin production by rat liver in organ culture, Acta Endocrinol. 99: 422 (1982).PubMedGoogle Scholar
  159. 153.
    C. D. Scott, J. L. Martin, and R. C. Baxter, Rat hepatocyte insulin-like growth factor-I and binding protein: Effect of growth hormone in vitro and in vivo, Endocrinology. 116: 1102 (1985).PubMedCrossRefGoogle Scholar
  160. 154.
    M. Berelowitz, M. Szabo, L. A. Frohman, S. Firestone, L. Chu, and R. L. Hintz, Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary, Science. 212: 1279 (1981).PubMedCrossRefGoogle Scholar
  161. 155.
    P. Brazeau, R. Guillemin, N. Ling, J. Van Wyk, and R. Humbel, Inhibition by somatomedin of growth hormone secretion stimulated by hypothalamic growth hormone releasing factor (somatocrinin, GRF) or the synthetic peptide hpGRF, C.R. Acad. Sci. [D] Paris. 295: 651 (1982).Google Scholar
  162. 156.
    C. G. Goodyer, L. De Stephano, H. J. Guyda, and B. I. Posner, Effects of insulin-like growth factors on adult male rat pituitary function in tissue culture, Endocrinology. 115: 1568 (1984).PubMedCrossRefGoogle Scholar
  163. 157.
    S. Yamashita, and S. Melmed, Insulin-like growth factor I action on rat anterior pituitary cells: Suppression of growth hormone secretion and messenger ribonucleic acid levels, Endocrinology. 118: 176 (1986).PubMedCrossRefGoogle Scholar
  164. 158.
    S. Melmed, and S. Yamashita, Insulin-like growth factor-I action on hypothyroid rat pituitary cells: Suppression of triiodothyronine-induced growth hormone secretion and messenger ribonucleic acid levels, Endocrinology 118: 1483 (1986).PubMedCrossRefGoogle Scholar
  165. 159.
    S. Yamashita, M. Weiss, and S. Melmed, Insulin-like growth factor I regulates growth hormone secretion and messenger ribonucleic acid levels in human pituitary tumor cells, J. Clin. Endocrinol. Metab. 63: 730 (1986).PubMedCrossRefGoogle Scholar
  166. 160.
    M. S. Sheppard, and R. M. Bala, Insulin-like growth factor inhibition of growth hormone secretion, Can. J. Physiol. Pharmacol. 64: 525 (1986).PubMedCrossRefGoogle Scholar
  167. 161.
    R. C. Baxter, Z. Zaltsman, J. R. Oliver, and J. O. Willughby, Pulsatility of immunoreactive somatomedin-C in chronically cannulated rats, Endocrinology. 113: 729 (1983).PubMedCrossRefGoogle Scholar
  168. 162.
    G. S. Tannenbaum, H. J. Guyda, and B. I. Posner, Insulin-like growth factors: A role in growth hormone negative feedback and body weight regulation, Science. 220: 77 (1983).PubMedCrossRefGoogle Scholar
  169. 163.
    H. Abe, M. E. Molitch, J. J. Van Wyk, and L. E. Underwood, Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats, Endocrinology. 113: 1319 (1983).PubMedCrossRefGoogle Scholar
  170. 164.
    T. Tanaka, H. Maesaka, and S. Suwa, Changes in somatomedin activity in anorexia nervosa, Endocrinol. Japon. 32: 891 (1985).CrossRefGoogle Scholar
  171. 165.
    L. S. Phillips, and R. Vassilopoulou-Sellin, Somatomedins, N. Engl. J. Med. 302: 371 (1980).PubMedCrossRefGoogle Scholar
  172. 166.
    E. R. Froesch, C. Schmid, J. Schwander, and J. Zapf, Actions of insulin-like growth factors, Ann. Rev. Physiol. 47: 443 (1985).CrossRefGoogle Scholar
  173. 167.
    J. J. Van Wyk, L. E. Underwood, A. J. D’Ercole, D. R. Clemmons, W. J. Pledger, W. R. Wharton, and E. B. Leof, Role of somatomedins in cellular proliferation, in: “The biology of normal human growth,” M. Ritzen, A. Aperia, K. Hall, A. Larsson, A. Zetterberg, and R. Zetterstrom, eds., Raven, New York (1981).Google Scholar
  174. 168.
    H. Rothstein, Regulation of the cell cycle by somatomedins, Int. Rev. Cytol. 78: 127 (1982).PubMedCrossRefGoogle Scholar
  175. 169.
    H. Rothstein, J. J. Van Wyk, J. H. Hayden S. R. Gordon, and A. Weinsieder, An in vivo study with somatomedin-C: Restoration of cycle traverse in GO/G1 blocked cells of hypophysectomized animals, Science. 208: 410 (1980).PubMedCrossRefGoogle Scholar
  176. 170.
    L. S. Phillips, and R. Vassilopoulou-Sellin, Somatomedins, N. Engl. J. Med. 302: 438 (1980).PubMedCrossRefGoogle Scholar
  177. 171.
    E. Schoenle, J. Zapf, and E. R. Froesch, Insulin-like growth factors I and II stimulate growth of hypophysectomized rats, Diabetologia. 23: 199 (1982).Google Scholar
  178. 172.
    V. R. Sara, M. C. Stuart, R. Rutherford, S. Moore, and L. Lazarus, Brain growth-promoting activity in human serum: Relationship to growth hormone and somatomedin, J. Clin. Endocrinol. Metab. 47: 1129 (1978).PubMedCrossRefGoogle Scholar
  179. 173.
    L. Fryklund, K. Uthne, H. Sievertsson, and B. Westermark, Isolation and characterization of polypeptides from human plasma: Enhancing the growth of human normal cells in culture, Biochem. Biophys. Res. Commun. 61: 950 (1974).CrossRefGoogle Scholar
  180. 174.
    D. Lenoir and P. Honegger, Insulin-like growth factor I (IGF I) stimulates DNA synthesis in fetal rat brain cell cultures, Dev. Brain Res. 7: 205 (1983).CrossRefGoogle Scholar
  181. 175.
    E. Recio-Pinto and D. N. Ishii, Effects of insulin, insulin-like growth factor-II and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells, Brain Res. 302: 323 (1984).PubMedCrossRefGoogle Scholar
  182. 176.
    J. F. Mill, M. V. Chao, and D. N. Ishii Insulin, insulin-like growth factor II, and nerve growth factor effects on tubulin mRNA levels and neurite formation, Proc. Natl. Acad. Sci., U.S.A. 82: 7126 (1985).CrossRefGoogle Scholar
  183. 177.
    M. Bothwell, Insulin and somatomedin MSA promote nerve growth factor-independent neurite formation by cultured chick dorsal root ganglionic sensory neurons, J. Neurosci. Res. 8: 225 (1982).PubMedCrossRefGoogle Scholar
  184. 178.
    E. Recio-Pinto, M. M. Rechler, and D. N. Ishii, Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons, J. Neurosci. 6: 1211 (1986).PubMedGoogle Scholar
  185. 179.
    Y. Aizenman, and J. de Vellis, Brain neuron development in a hormonally defined glial-free environment: Effects of transferrin, insulin, insulin-like growth factor-I and thyroid hormone, Soc. Neurosci. Abst. 12: 1104 (1986).Google Scholar
  186. 180.
    E. Recio-Pinto, F. F. Lang, and D. N. Ishii, Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells, Proc. Natl. Acad. Sci., U.S.A. 81: 2562 (1984).PubMedCrossRefGoogle Scholar
  187. 181.
    S. D. Balk, A. Morisi, H. S. Gunther, M. F. Svoboda, J. J. Van Wyk, S. P. Nissley, and C. G. Scanes, Somatomedins (insulin-like growth factors), but not growth hormone, are mitogenic for chicken heart mesenchymal cells and act synergistically with epidermal growth factor and brain fibroblast growth factor, Life Sci. 35: 335 (1984).PubMedCrossRefGoogle Scholar
  188. 182.
    W. J. Pledger, C. D. Stiles, H. N. Antoniades, and C. D. Scher, An ordered sequence of events is required before BALB/C-3T3 cells become committed to DNA synthesis, Proc. Natl. Acad. Sci., U.S.A. 75: 2834 (1978).CrossRefGoogle Scholar
  189. 183.
    C. D. Stiles, G. T. Capone, and C. D. Scher, Dual control of cell growth by somatomedins and platelet-derived growth factor, Proc. Natl. Acad. Sci., U.S.A. 76: 1279 (1979).PubMedCrossRefGoogle Scholar
  190. 184.
    D. R. Clemmons, and J. J. Van Wyk, Somatomedin-C and platelet-derived growth factor stimulate human fibroblast replication, J. Cell. Physiol. 106: 361 (1981).PubMedCrossRefGoogle Scholar
  191. 185.
    H. A. Hansson, L. B. Dahlin, N. Danielsen, L. Fryklund, A. K. Nachemson, P. Polleryd, B. Rozell, A. Skottner, S. Stemme, and G. Lundborg, Evidence indicating trophic importance of IGF-I in regenerating peripheral nerves, Acta Physiol. Scand. 126: 609 (1986).CrossRefGoogle Scholar
  192. 186.
    C. R. Plata-Salamân, Y. Oomura, and N. Shimizu, Dependence of food intake on acute and chronic ventricular administration of insulin, Physiol. Behay. 37: 717 (1986).CrossRefGoogle Scholar
  193. 187.
    V. R. Sara, K. Hall, M. Rutter, L. Wetterberg, and A. Yuwiler, Hormonal regulation of brain growth: Implications for mental retardation, in: “Biological Psychiatry,” C. Perris, G. Struwe and B. Jansson, eds., Elsevier, North Holland (1981).Google Scholar
  194. 188.
    V. R. Sara, K.-H. Gustaysson, G. Annerén, K. Hall, and L. Wetterberg, Somatomedins in Down’s syndrome, Biol. Psychiatr. 18: 803 (1983).Google Scholar
  195. 189.
    G. Annerén, V. R. Sara, K. Hall, and T. Tuvemo, Growth and somatomedin responses to growth hormone in Down’s syndrome, Arch. Dis. Childhood. 61: 48 (1986).CrossRefGoogle Scholar
  196. 190.
    G. Annerén, G. Enberg, and V. R. Sara, The presence of normal levels of serum immunoreactive insulin-like growth factor 2(IGF-2) in patients with Down’s syndrome, Ups. J. Med. Sci. 89: 274 (1984).PubMedCrossRefGoogle Scholar
  197. 191.
    B. Draznin, P. J. Burstein, U. E. Heinrich, C. J. Johnson, C. A. Emler, and D. S. Schalch, Insulin like growth factor and its carrier protein in hypopituitary and hypothyroid children and adults, Clin. Endocrinol. 12: 137 (1980).Google Scholar
  198. 192.
    J. Marek, M. Schullerova, O. Schreiberova, and Z. Limanova, Effect of thyroid function on serum somatomedin activity, Acta Endocrinol. 96: 491 (1981).PubMedGoogle Scholar
  199. 193.
    B. Kjellman, Cerebral gigantism, Acta Paediatr. Scand. 54: 603 (1965).CrossRefGoogle Scholar
  200. 194.
    M. V. L. Ducaju, and J. L. Van den Brande, Plasma somatomedin levels in growth disturbances, Acta Paediatr. Scand. 62: 96 (1973).Google Scholar
  201. 195.
    T. Sakano, T. Yoshimitsu, A. Tanabe, T. Tanaka, Y. Kobayashi, T. Usui, and K. Takano, Cerebral gigantism: A report of two cases with elevated serum somatomedin A levels and a review of the Japanese literature, Hirosh. J. Med. Sci. 26: 311 (1977).Google Scholar
  202. 196.
    J. M. Wit, F. A. Beemer, P. G. Barth, J. W. E. Oorthuys, P. F. Dijkstra, J. L. Van den Brande, and N. J. Leschot, Cerebral gigantism (Sotos syndrome). Compiled data of 22 cases, Eur. J. Pediatr. 144: 131 (1985).PubMedCrossRefGoogle Scholar
  203. 197.
    V. R. Sara, K. Hall, K. Enzell, A. Gardner, R. Morawski, and L. Wetterberg, Somatomedins in aging and dementia disorders of the Alzheimer’s type, Neurobiol. Aging. 3: 117 (1982).Google Scholar
  204. 198.
    H. Von Holst, and V. Sara, Increased levels of somatomedins in human lumbar and central cerebrospinal fluid after subarachnoid haemorrhage, Acta Neurochirurgica. 78: 157 (1985).CrossRefGoogle Scholar
  205. 199.
    W. V. Tamborlane, R. L. Hintz, M. Bergman, M. Genel, P. Felig, and R. S. Sherwin, Insulin infusion pump treatment of diabetics influence of improved metabolic control on plasma somatomedin levels, N. Engl. J. Med. 305: 303 (1981).PubMedCrossRefGoogle Scholar
  206. 200.
    S. A. Amiel, R. S. Sherwin, R. L. Hintz, J. M. Gertner, C. M. Press, and W. V. Tamborlane, Effect of Diabetes and its control on insulin-like growth factors in the young subject with type I Diabetes, Diabetes. 33: 1175 (1984).PubMedCrossRefGoogle Scholar
  207. 201.
    L. S. Phillips, A. C. Fusco, and T. G. Unterman, Nutrition and somatomedin. XIV. Altered levels of somatomedins and somatomedin inhibitors in rats with streptozotocin-induced Diabetes, Metabolism. 34: 765 (1985).PubMedCrossRefGoogle Scholar
  208. 202.
    T. W. Sadler, L. S. Phillips, W. Balkan, and S. Goldstein, Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture, Diabetes 35: 861 (1986).PubMedCrossRefGoogle Scholar
  209. 203.
    A. S. Goustin, E. B. Leof, G. D. Shipley, and H. L. Moses, Growth factors and cancer, Cancer Res. 46: 1015 (1986).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Yutaka Oomura
    • 1
  • Carlos R. Plata-Salamán
    • 1
  1. 1.Department of Physiology Faculty of MedicineKyushu University 60Fukuoka 812Japan

Personalised recommendations